A · Agilent Technologies Inc
Price
Snapshot
50 fields · last close| Market Cap | $42.28B |
| P/E | 29.65 |
| Float | 281.9M |
| Beta | 1.27 |
| Volatility | 31.8% |
| Exchange | NYSE |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | High |
| Clavix score | 74 |
| Price | 150.70 |
| Change | +0.48% |
| Prev Close | 149.98 |
| Open | 152.63 |
| Day Low | 147.81 |
| Day High | 154.29 |
| Avg Vol | 3 |
| Avg $ Vol | $447.9M |
| 52W High | 163.75 |
| 52W Low | 108.35 |
| 52W Pos | 76.4% |
| From High | −7.97% |
| From Low | +39.09% |
| Max DD 1Y | −29.87% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −0.77% |
| SMA 50 | +6.11% |
| SMA 200 | +14.55% |
| RSI (14) | 52.5 |
| Vol 30D | 25.9% |
| Vol 90D | 39.0% |
| 1Y Range | 108–164 |
| Daily bars | 865 |
| Perf Week | −4.89% |
| Perf Month | +6.29% |
| Perf Quarter | +8.39% |
| Perf Half Y | +26.98% |
| Perf Year | +19.77% |
| Perf YTD | +9.24% |
| Prev Day | +0.48% |
| Clavix | B |
| Debt / Eq | 0.45 |
| Curr Ratio | 1.96 |
| Int Cover | 29.1× |
| FCF Margin | 16.6% |
| Rev Growth | +0.1% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 7 / 19 |
What A does
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses.
The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services.
This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise.
In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software.
The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments.
It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Clavix risk grade
regraded every trading dayA grades B, 74 of 100. Steadiest on Macro Resilience (66), most exposed on News Sentiment (56, mixed). 2 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 7 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| A | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.27 | 1.19 |
| Volatilityannualized | 31.8% | 29.7% |
| Max drawdown, past yearworst peak-to-trough fall | −29.9% | — |
| Typical daily movemedian absolute daily change | 1.01% | — |
| Days beyond ±3%of the last 252 sessions | 2510% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| A | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.27 | 1.19 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate47% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| A | |
|---|---|
| 1 week | −4.9% |
| 1 month | +6.3% |
| Year to date | +9.2% |
| 1 year | +19.8% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| A | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 4 Aug |
| Average score0 most bearish, 100 most bullish | 43 |
| Bullish · bearisharticles above 60 · below 40 | 10 · 18 |
| Directionarticles whose tone is improving vs worsening | 10 ↑ 18 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| A | |
|---|---|
| Revenue growthyear over year | +0.1% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Life Sciences Tools & Services
19 companies| Metric | A | Sector spread | Median |
|---|---|---|---|
| Beta | 1.27 | 1.19 | |
| Volatility | 31.8% | 29.7% | |
| P/E | 29.65 | 36.77 | |
| Debt / equity | 0.45 | 0.51 | |
| Current ratio | 1.96 | 1.89 | |
| FCF margin | 16.6% | 19.5% | |
| Interest coverage | 29.1× | 3.5× |
Recent news
most recent scored articles · the chip is the article’s score · click to openTexas Governor Greg Abbott ordered state agencies to stop funding AI-powered Flock Safety cameras amid privacy concerns, while a growing number of Texas cities and counties are independently cancelling their contracts with the company. Flock Safety is one of the most widely used providers of automated license plate readers (ALPRs), which photograph passing vehicles and use AI to detect characteristics like make, model, color, and bumper stickers.
Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% from a year earlier, with core revenue (which strips out currency moves and acquisitions) growing 7.3%. Its adjusted operating margin reached 28.3%, expanding 320 basis points year-over-year, but roughly 110 basis points of that gain came from one-time tariff refunds, meaning the underlying margin improvement was about 210 basis points.
Anthropic released a research preview of its Model Hardware Standard (MHS), a tool that lets its AI assistant Claude control lab equipment such as microscopes, liquid handlers, lasers, and robotic arms to run physical experiments. The technology was built with HHMI Janelia Research Campus and tested with partners including Carnegie Mellon University, Genentech, and QuEra.
Menlo Park Police will cancel all its existing data-sharing agreements with Flock Safety after a June audit found a regional anti-crime organization ran roughly 700 searches that broke the department's data-sharing rules. This is the second time since 2025 that an outside group misused the license plate reader data Flock supplies, and it adds Menlo Park to a growing list of Bay Area cities pulling back from the company's cameras.
Two Arizona cities turned off Flock's license-plate reader cameras on Wednesday and will not replace the system, while Senator Hawley opened a formal investigation into the company the same day and Senator Sanders announced plans for legislation against it.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| IQV | IQVIA Holdings Inc | B- | $44.71B | 32.10 | 1.18 | Compare |
| WAT | Waters Corp | B | $37.34B | 243.61 | 1.19 | Compare |
| ILMN | Illumina Inc | B- | $33.47B | 39.20 | 1.48 | Compare |
| MTD | Mettler-toledo International Inc | B+ | $27.17B | 29.97 | 1.21 | Compare |
| WST | West Pharmaceutical Services Inc | B+ | $23.90B | 42.69 | 1.16 | Compare |
| MEDP | Medpace Holdings Inc | B- | $16.56B | 33.64 | 1.13 | Compare |
| RVTY | Revvity Inc | B | $14.58B | 61.02 | 1.11 | Compare |
| CRL | Charles River Laboratories International Inc | B- | $14.00B | — | 1.40 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.